...
首页> 外文期刊>The Egyptian Journal of Hospital Medicine >Serum Low Density Lipoprotein and Serum High Sensitive C - Reactive Protein as a Diagnostic Markers for Acute Coronary Syndrome
【24h】

Serum Low Density Lipoprotein and Serum High Sensitive C - Reactive Protein as a Diagnostic Markers for Acute Coronary Syndrome

机译:血清低密度脂蛋白和血清高敏C反应蛋白作为急性冠脉综合征的诊断标志。

获取原文

摘要

Background: Acute coronary syndrome (ACS) remains the major cause of mortality and morbidity in the worldwide. Low density lipoprotein- cholesterol (LDL-C) level is a major risk factor for the development of ACS, and pathogenesis of atherosclerosis. Atherosclerosis is a multi-step disease and characterized by chronic low-grade vascular inflammation, which plays a role in its every stage from onset, progression and finally to plaque rupture then triggers ACS. Elevation of high Sensitive C-reactive protein (hs-CRP) is a strong and independent predictor of cardiovascular disease. The objective of this work was to evaluate the role of serum LDL-C and serum hs-CRP in patients with ACS. Patients and Method: The current study enrolled 45 patients with confirmed ACS and 30 apparently healthy persons of matching age and sex as control group. The patients were subdivided into three subgroups each one included 15 patients: Subgroup A: ST-segment elevation myocardial infarction (STEMI). Sub-group B: Non-ST-segment elevation myocardial infarction (NSTEMI), Subgroup C: Unstable angina pectoris (UAP). All patients and control groups were subjected to measurement of low density lipoprotein- cholesterol (LDL-C), high density lipoprotein- cholesterol (HDL-C), total cholesterol, triglyceride, highly sensitive CRP (hs-CRP), cardiac troponin I (cTnI), and creatine kinase-MB fraction (CK-MB), electrocardiography (ECG) and trans-thoracic-echocardiography. Results: There was highly significant increase of serum LDL-C and serum hs-CRP in group I as compared to group II (P=0.001) and significant increase of serum LDL-C ((P<0.05) and highly significant increase of serum hs-CRP (P=0.01) in STEMI and NSTEMI subgroups when compared to UAP subgroup and highly significant increase of serum LDL-C (P=0.005) and serum hs-CRP(P=0.003) in UAP sub-group when compared to group II . There was also, a positive significant correlation between serum LDL-C and both serum CK-MB and serum hs- CRP in all subgroups. Conclusion: Elevated serum LDL and hs-CRP may serve as markers of the severity of the disease which help evaluation and management of ACS patients
机译:背景:急性冠状动脉综合征(ACS)仍然是全球范围内死亡率和发病率的主要原因。低密度脂蛋白胆固醇(LDL-C)水平是ACS以及动脉粥样硬化发病机理的主要危险因素。动脉粥样硬化是一种多步骤疾病,其特征是慢性低度血管炎症,它在从发病,发展到最后直至斑块破裂的每个阶段均起作用,然后触发ACS。高敏感的C反应蛋白(hs-CRP)升高是心血管疾病的强有力且独立的预测因子。这项工作的目的是评估血清LDL-C和血清hs-CRP在ACS患者中的作用。患者和方法:本研究招募了45例确诊为ACS的患者和30名年龄和性别相匹配的显然健康的人作为对照组。将患者分为三个亚组,每个亚组包括15名患者:A组:ST段抬高型心肌梗塞(STEMI)。 B组:非ST段抬高型心肌梗塞(NSTEMI),C组:不稳定型心绞痛(UAP)。所有患者和对照组均接受低密度脂蛋白胆固醇(LDL-C),高密度脂蛋白胆固醇(HDL-C),总胆固醇,甘油三酸酯,高敏CRP(hs-CRP),心肌肌钙蛋白I( cTnI),肌酸激酶-MB分数(CK-MB),心电图(ECG)和经胸超声心动图。结果:与第二组相比,第一组血清LDL-C和hs-CRP显着升高(P = 0.001),血清LDL-C显着升高((P <0.05),血清显着升高与UAP小组相比,STEMI和NSTEMI小组中的hs-CRP(P = 0.01)和UAP小组中的血清LDL-C(P = 0.005)和hs-CRP(P = 0.003)显着增加第二组。所有亚组的血清LDL-C与血清CK-MB和hs-CRP均呈显着正相关。结论:血清LDL和hs-CRP升高可能是疾病严重程度的标志帮助评估和管理ACS患者

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号